Form 483

Nevro Corporation Form 483, 2025-08-13

FDA issued a Form 483 to Nevro Corporation on 2025-08-13 with 6 public-safe observations.

483· Form 483 issuedMedical Devices & Rad Health6 observations

Nevro Corporation · Redwood City, United States · Issued August 13, 2025

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 Aug 2025
21 CFR 803.50(a)(1)

Report of Death or Serious Injury

Cited by Shannon A Gregory, Brittany D Mccracken

13 Aug 2025
21 CFR 820.100(b)

Documentation

Cited by Shannon A Gregory, Brittany D Mccracken

13 Aug 2025
21 CFR 820.198(a)

Complaints

Cited by Shannon A Gregory, Brittany D Mccracken

13 Aug 2025
21 CFR 820.30(g)

Design validation- Lack of or inadequate procedures

Cited by Shannon A Gregory, Brittany D Mccracken

13 Aug 2025
21 CFR 820.70(a)

Production processes

Cited by Shannon A Gregory, Brittany D Mccracken

Inspected site

NCNevro CorporationRedwood City, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 803.50(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 820.100(b)Cited across public-safe Form 483 observations1x
21 CFR 820.198(a)Cited across public-safe Form 483 observations1x
21 CFR 820.30(g)Cited across public-safe Form 483 observations1x
21 CFR 820.70(a)Cited across public-safe Form 483 observations1x
21 CFR 820.75(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 6 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere